Does GOLIMUMAB Cause Maternal exposure during pregnancy? 4,983 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 4,983 reports of Maternal exposure during pregnancy have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 7.2% of all adverse event reports for GOLIMUMAB.
4,983
Reports of Maternal exposure during pregnancy with GOLIMUMAB
7.2%
of all GOLIMUMAB reports
1,192
Deaths
1,565
Hospitalizations
How Dangerous Is Maternal exposure during pregnancy From GOLIMUMAB?
Of the 4,983 reports, 1,192 (23.9%) resulted in death, 1,565 (31.4%) required hospitalization, and 1,478 (29.7%) were considered life-threatening.
Is Maternal exposure during pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 4,983 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Maternal exposure during pregnancy?
CERTOLIZUMAB PEGOL (9,013)
ADALIMUMAB (7,518)
PREDNISONE (6,587)
METHOTREXATE (6,223)
RITUXIMAB (6,093)
INFLIXIMAB (6,061)
HYDROXYCHLOROQUINE (5,809)
FOLIC ACID (5,768)
TOCILIZUMAB (5,737)
LEFLUNOMIDE (5,643)
Which GOLIMUMAB Alternatives Have Lower Maternal exposure during pregnancy Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN